EB134

January 2014
Geneva

Agenda

2
Report of DG
3
Report of PBAC
4
Report of RCs to the EB
5
WHO Reform
5.1
Reform implementation plan and report
5.2
Options for improved decision making by governing bodies
5.3
Streamlining national reporting and communication with MSs
5.4
Framework for engagement with non-State actors
5.5
Financing dialogue
5.6
Strategic resource allocation
5.7
Financing of administrative and management costs
6
Communicable disease
6.1
Global strategy and targets for tuberculosis prevention, care and control after 2015
6.2
GVAP
7
Noncommunicable diseases
7.1
Follow-up of the HLM of the UNGA on the Prevention and Control of NCDs
7.2
Maternal, infant and young child nutrition
7.3
Disability
8
Promoting health through the life course
8.1
Monitoring the achievement of the MDGs
8.2
Multisectoral action for a life course approach to healthy ageing
8.3
Nameless item
8.4
Addressing the global challenge of violence, in particular against women and girls
8.5
International code of conduct on pesticide management
8.7
Contributing to social and economic development: sustainable action across sectors to improve health and health equity
9
Health systems
9.1
Traditional medicine
9.2
Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
9.3
Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
9.4
Strengthening of palliative care as a component of integrated treatment throughout the life course
9.5
Regulatory system strengthening
9.6
Health intervention and technology assessment in support of universal health coverage
9.7
Access to essential medicines
9.8
Follow-up of the Recife Political Declaration on Human Resources for Health: renewed commitments towards universal health coverage
10
Preparedness, surveillance and response
10.2
Pandemic Influenza Preparedness: sharing of influenza virus and access to vaccines and other benefits
10.3
Smallpox eradication: destruction of variola virus stocks
10.4
Poliomyelitis: intensification of the global eradication initiative
10.5
Hepatitis
10.6
Antimicrobial drug resistance
11
Management, financial and legal matters
11.1
Evaluation
11.2
Amendments to the Financial Regulations and Financial Rules
11.3
Real estate: updated on the Geneva buildings renovation strategy
11.4
Hosted health partnerships
11.5
Follow-up of the report of the Working Group on the Election of the Director-General of the World Health Organization
11.6
Reports of committees of the EB
11.7
Provisional agenda of the Sixty-seventh World Health Assembly and date and place of the 135th session of the Executive Board
12
Staffing matters
12.1
Appointment of RD for SEA
12.2
Appointment of RD for WPR
12.3
Statement by representative of staff associations
12.4
Human resources
12.5
Report of the International Civil Service Commission
12.6
Amendments to the Staff Regulations and Staff Rules
13
Matters for information
13.1
Reports of advisory bodies
13.2
Progress reports
14
Closure